Timothy Chan, M.D., Ph.D.
Director, Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic

Dr. Chan joins Cleveland Clinic from Memorial Sloan Kettering Cancer Center and Weill Cornell School of Medicine, where he leads the Immunogenomics and Precision Oncology Platform and was a tenured professor, the Paine Webber chair, and the Translational Oncology Division chair.

Dr. Chan is an internationally recognized expert in precision immuno-oncology, and a pioneer in using genomics to determine which patients will respond best to certain types of immunotherapies. He has published over 200 articles in peer-reviewed journals, has made landmark discoveries in his field, and has received numerous awards, including the National Cancer Insititute Outstanding Investigator Award in 2018.